{"downloaded": true, "htmlmade": false, "full": {"id": "30179587", "source": "MED", "pmid": "30179587", "pmcid": "PMC6415919", "fullTextIdList": {"fullTextId": "PMC6415919"}, "doi": "10.1016/j.trsl.2018.08.002", "title": "Precision medicine in lupus nephritis: can biomarkers get us there?", "authorString": "Caster DJ, Merchant ML, Klein JB, Powell DW.", "authorList": {"author": [{"fullName": "Caster DJ", "firstName": "Dawn J", "lastName": "Caster", "initials": "DJ", "authorId": {"@type": "ORCID", "#text": "0000-0001-9106-471X"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky; Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky. Electronic address: dawn.caster@louisville.edu."}}}, {"fullName": "Merchant ML", "firstName": "Michael L", "lastName": "Merchant", "initials": "ML", "authorId": {"@type": "ORCID", "#text": "0000-0003-4128-4057"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky."}}}, {"fullName": "Klein JB", "firstName": "Jon B", "lastName": "Klein", "initials": "JB", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky; Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky."}}}, {"fullName": "Powell DW", "firstName": "David W", "lastName": "Powell", "initials": "DW", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-9106-471X"}, {"@type": "ORCID", "#text": "0000-0003-4128-4057"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"volume": "201", "journalIssueId": "2736632", "dateOfPublication": "2018 Nov", "monthOfPublication": "11", "yearOfPublication": "2018", "printPublicationDate": "2018-11-01", "journal": {"title": "Translational research : the journal of laboratory and clinical medicine", "ISOAbbreviation": "Transl Res", "medlineAbbreviation": "Transl Res", "NLMid": "101280339", "ISSN": "1931-5244", "ESSN": "1878-1810"}}, "pubYear": "2018", "pageInfo": "26-39", "abstractText": "Patients with systemic lupus erythematosus frequently develop lupus nephritis (LN), a condition that can lead to end-stage kidney disease. Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of studies have been single center with significant variability in cohorts, assays, and sample storage, leading to inconclusive results. It has become clear that no single biomarker is likely to be sufficient to diagnose LN, identify flares, and define the response to therapy and prognosis. A more likely scenario is a panel of urine, serum, tissue, and genetic biomarkers. In this review, we summarize traditional and novel biomarkers and discuss how they may be utilized in order to bring precision medicine to clinical practice in LN.", "affiliation": "Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky; Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky. Electronic address: dawn.caster@louisville.edu.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["research-article", "Review", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": {"grantId": "K08 DK102542", "agency": "NIDDK NIH HHS", "acronym": "DK", "orderIn": "0"}}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Lupus Nephritis", "meshQualifierList": {"meshQualifier": {"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Phosphopyruvate Hydratase", "meshQualifierList": {"meshQualifier": {"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Annexins", "meshQualifierList": {"meshQualifier": {"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "MicroRNAs", "meshQualifierList": {"meshQualifier": {"abbreviation": "UR", "qualifierName": "urine", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Complement Pathway, Alternative"}, {"majorTopic_YN": "N", "descriptorName": "Complement Pathway, Classical"}, {"majorTopic_YN": "N", "descriptorName": "Biomarkers", "meshQualifierList": {"meshQualifier": {"abbreviation": "AN", "qualifierName": "analysis", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "Y", "descriptorName": "Precision Medicine"}]}, "chemicalList": {"chemical": [{"name": "Phosphopyruvate Hydratase", "registryNumber": "EC 4.2.1.11"}, {"name": "Annexins", "registryNumber": "0"}, {"name": "MicroRNAs", "registryNumber": "0"}, {"name": "Biomarkers", "registryNumber": "0"}]}, "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1016/j.trsl.2018.08.002"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6415919"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6415919?pdf=render"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1016/j.trsl.2018.08.002"}]}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "2", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "authMan": "Y", "epmcAuthMan": "N", "nihAuthMan": "Y", "manuscriptId": "NIHMS1506203", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "refsnp"}, "dateOfCompletion": "2019-01-23", "dateOfCreation": "2018-09-05", "firstIndexDate": "2018-09-05", "fullTextReceivedDate": "2020-10-09", "dateOfRevision": "2020-02-25", "electronicPublicationDate": "2018-08-10", "firstPublicationDate": "2018-08-10", "embargoDate": "2019-11-01"}, "abstract": "Patients with systemic lupus erythematosus frequently develop lupus nephritis (LN), a condition that can lead to end-stage kidney disease. Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of studies have been single center with significant variability in cohorts, assays, and sample storage, leading to inconclusive results. It has become clear that no single biomarker is likely to be sufficient to diagnose LN, identify flares, and define the response to therapy and prognosis. A more likely scenario is a panel of urine, serum, tissue, and genetic biomarkers. In this review, we summarize traditional and novel biomarkers and discuss how they may be utilized in order to bring precision medicine to clinical practice in LN.", "journaltitle": "Translational research : the journal of laboratory and clinical medicine", "authorinfo": ["Caster DJ", "Merchant ML", "Klein JB", "Powell DW"], "title": "Precision medicine in lupus nephritis: can biomarkers get us there?"}